Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

A medical nutriment has supportive value in the treatment of colorectal cancer.

Jakab F, Shoenfeld Y, Balogh A, Nichelatti M, Hoffmann A, Kahán Z, Lapis K, Mayer A, Sápy P, Szentpétery F, Telekes A, Thurzó L, Vágvölgyi A, Hidvégi M.

Br J Cancer. 2003 Aug 4;89(3):465-9.

2.

[Fermented wheat germ extract in the supportive therapy of colorectal cancer].

Farkas E.

Orv Hetil. 2005 Sep 11;146(37):1925-31. Hungarian.

PMID:
16255377
3.

Fermented wheat germ extract reduces chemotherapy-induced febrile neutropenia in pediatric cancer patients.

Garami M, Schuler D, Babosa M, Borgulya G, Hauser P, Müller J, Paksy A, Szabó E, Hidvégi M, Fekete G.

J Pediatr Hematol Oncol. 2004 Oct;26(10):631-5.

PMID:
15454833
4.

First clinical data of a natural immunomodulator in colorectal cancer.

Jakab F, Mayer A, Hoffmann A, Hidvégi M.

Hepatogastroenterology. 2000 Mar-Apr;47(32):393-5.

PMID:
10791198
5.
6.

Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.

Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, Cardaci G, Gray B.

J Surg Oncol. 2004 Nov 1;88(2):78-85.

PMID:
15499601
7.

Cetuximab for the treatment of colorectal cancer.

Jonker DJ, O'Callaghan CJ, Karapetis CS, Zalcberg JR, Tu D, Au HJ, Berry SR, Krahn M, Price T, Simes RJ, Tebbutt NC, van Hazel G, Wierzbicki R, Langer C, Moore MJ.

N Engl J Med. 2007 Nov 15;357(20):2040-8.

8.

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shapiro JD, Robitaille S, Price TJ, Shepherd L, Au HJ, Langer C, Moore MJ, Zalcberg JR.

N Engl J Med. 2008 Oct 23;359(17):1757-65. doi: 10.1056/NEJMoa0804385.

9.

Influence of a complementary treatment with oral enzymes on patients with colorectal cancers--an epidemiological retrolective cohort study.

Popiela T, Kulig J, Hanisch J, Bock PR.

Cancer Chemother Pharmacol. 2001 Jul;47 Suppl:S55-63.

PMID:
11561874
10.

A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):282-308. Review.

PMID:
11441937
11.

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.

Van Cutsem E, Köhne CH, Hitre E, Zaluski J, Chang Chien CR, Makhson A, D'Haens G, Pintér T, Lim R, Bodoky G, Roh JK, Folprecht G, Ruff P, Stroh C, Tejpar S, Schlichting M, Nippgen J, Rougier P.

N Engl J Med. 2009 Apr 2;360(14):1408-17. doi: 10.1056/NEJMoa0805019.

12.

Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE).

Polite BN, Sing A, Sargent DJ, Grothey A, Berlin J, Kozloff M, Feng S.

Cancer. 2012 Feb 15;118(4):1083-90. doi: 10.1002/cncr.26394. Epub 2011 Jul 28.

13.

Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer.

Hansen RM, Ryan L, Anderson T, Krzywda B, Quebbeman E, Benson A 3rd, Haller DG, Tormey DC.

J Natl Cancer Inst. 1996 May 15;88(10):668-74.

PMID:
8627643
14.

Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.

Tappenden P, Jones R, Paisley S, Carroll C.

Health Technol Assess. 2007 Mar;11(12):1-128, iii-iv. Review.

15.

Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival.

Heslin MJ, Medina-Franco H, Parker M, Vickers SM, Aldrete J, Urist MM.

Arch Surg. 2001 Mar;136(3):318-23. Erratum in: Arch Surg 2001 Jul;136(7):809.

PMID:
11231853
16.

Indicators for surgical resection and intraoperative radiation therapy for pelvic recurrence of colorectal cancer.

Hashiguchi Y, Sekine T, Kato S, Sakamoto H, Nishimura Y, Kazumoto T, Sakura M, Tanaka Y.

Dis Colon Rectum. 2003 Jan;46(1):31-9.

PMID:
12544519
18.

A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer.

Kumar R, Jain K, Beeke C, Price TJ, Townsend AR, Padbury R, Roder D, Young GP, Richards A, Karapetis CS.

Cancer. 2013 Feb 15;119(4):722-8. doi: 10.1002/cncr.27802. Epub 2012 Sep 18.

19.

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.

Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Bertino JR, Turnbull AD, Sullivan D, Stockman J, Blumgart LH, Fong Y.

N Engl J Med. 1999 Dec 30;341(27):2039-48.

20.

Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years.

Ju JH, Chang SC, Wang HS, Yang SH, Jiang JK, Chen WC, Lin TC, Hung Hsu, Wang FM, Lin JK.

Int J Colorectal Dis. 2007 Aug;22(8):855-62. Epub 2007 Mar 28.

PMID:
17390145

Supplemental Content

Support Center